Item 7.01 Regulation FD Disclosure. On April 7,
Post# of 72440
Posted On: 04/08/2016 10:08:50 AM
Item 7.01 Regulation FD Disclosure.
On April 7, 2016, Dr. Francis A. Farraye, MD, MSc., joined the Cellceutix Advisory Board. Dr. Farraye is Clinical Director in the Section of Gastroenterology and Co-Director of the Center for Digestive Disorders at Boston Medical Center. He is also Professor of Medicine at the Boston University School of Medicine. Prior to accepting the position, Dr. Farraye consulted with Cellceutix to help design the protocol for its planned ulcerative proctitis clinical trial.
On April 7, 2016, Dr. Francis A. Farraye, MD, MSc., joined the Cellceutix Advisory Board. Dr. Farraye is Clinical Director in the Section of Gastroenterology and Co-Director of the Center for Digestive Disorders at Boston Medical Center. He is also Professor of Medicine at the Boston University School of Medicine. Prior to accepting the position, Dr. Farraye consulted with Cellceutix to help design the protocol for its planned ulcerative proctitis clinical trial.
(3)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼